만성 외상성 뇌병증 시장 보고서(2025년)

Chronic traumatic encephalopathy (CTE) is a neurological disorder caused by repeated head injuries over an extended period. It affects memory, cognitive abilities, and emotional regulation, resulting in confusion, mood fluctuations, and challenges in carrying out daily activities, often manifesting years after the initial injury.

The primary treatment methods for chronic traumatic encephalopathy include pharmacological therapies, rehabilitation programs, psychological support, surgical procedures, and alternative approaches. Pharmacological treatments involve using drugs such as anti-inflammatory agents and antidepressants to alleviate symptoms, decrease brain inflammation, and enhance daily functioning. Diagnosis is conducted through various methods including imaging scans, neurological assessments, biomarker analysis, among others. The condition is categorized into early-stage and advanced-stage CTE and is managed by different users such as hospitals, clinics, and research organizations.

The chronic traumatic encephalopathy market research report is one of a series of new reports from The Business Research Company that provides chronic traumatic encephalopathy market statistics, including the chronic traumatic encephalopathy industry global market size, regional shares, competitors with the chronic traumatic encephalopathy market share, detailed chronic traumatic encephalopathy market segments, market trends, opportunities, and any further data you may need to thrive in the chronic traumatic encephalopathy industry. This chronic traumatic encephalopathy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The chronic traumatic encephalopathy market size has grown strongly in recent years. It will grow from $1.39 billion in 2024 to $1.51 billion in 2025 at a compound annual growth rate (CAGR) of 8.8%. The growth during the historic period is due to greater awareness of sports-related head injuries, increased involvement in contact sports, a surge in military-related traumatic brain injuries, expanded research on neurodegenerative diseases, and improved access to diagnostic technologies.

The chronic traumatic encephalopathy market size is expected to see strong growth in the next few years. It will grow to $2.10 billion in 2029 at a compound annual growth rate (CAGR) of 8.5%. The growth projected for the forecast period is driven by increasing investments in neuroscience research, a rising demand for advanced diagnostic imaging, heightened emphasis on player safety regulations, expanding clinical studies on brain injuries, and growing public awareness about long-term brain health. Key trends during this period include progress in biomarker-based diagnostics, improved imaging techniques for early detection, development of disease-modifying treatments, innovations in wearable impact monitoring devices, and enhanced public awareness along with athlete screening initiatives.

The increasing number of head injuries is expected to drive growth in the chronic traumatic encephalopathy market in the future. Head injuries involve physical harm to the scalp, skull, or brain caused by an external impact or force. This rise in head injuries is largely due to more individuals participating in high-impact sports, which heightens the risk of traumatic brain injuries from collisions and accidents. Chronic traumatic encephalopathy (CTE) results from repeated head injuries that lead to the buildup of abnormal tau protein in the brain. This buildup progressively damages brain cells, causing cognitive decline and emotional issues. For example, in November 2024, the Tennessee Department of Health, a US government agency, reported that in 2023, 8,196 patients qualified for inclusion in the traumatic brain injury (TBI) Registry, representing a 2.4% increase from 2022. Thus, the growing occurrence of head injuries is fueling the expansion of the chronic traumatic encephalopathy market.

Leading companies in the chronic traumatic encephalopathy market are increasingly adopting advanced strategies, such as creating subsidiary companies, to speed up clinical trials and more effectively deliver innovative diagnostic and treatment options. A subsidiary is a separate legal entity owned or controlled by a parent company, which typically holds over 50% of its voting shares. This arrangement allows the parent company to enter new markets, reduce risks, and focus on specialized areas like research and development (R&D) or regional expansion. For example, in May 2023, Therapeutic Solutions International, a US biotechnology firm, established CTE Biologics Inc., a subsidiary to commercialize its clinical data and investigational new drug (IND) application for chronic traumatic encephalopathy (CTE) treatment using JadiCell universal adult stem cells. This subsidiary is dedicated to advancing JadiCell-based therapies for CTE-a neurodegenerative disorder commonly affecting athletes and military veterans-leveraging existing clinical data and ongoing regulatory engagement with the FDA to potentially begin formal clinical trials for this currently untreatable disease.

In March 2025, Enigma Biomedical USA Inc., a US biotechnology firm, collaborated with Boston University's chronic traumatic encephalopathy (CTE) center and the Concussion Legacy Foundation to promote early detection of CTE using advanced imaging techniques. This partnership focuses on validating 4R tau PET imaging biomarkers to enhance understanding and facilitate early diagnosis of CTE in living patients. The Concussion Legacy Foundation (CLF) is a US nonprofit organization, while the Boston University CTE Center is a US-based institution conducting cutting-edge research on chronic traumatic encephalopathy.

Major players in the chronic traumatic encephalopathy market are MedStar Health, NorthShore University Health System, Boston University, Mayo Foundation for Medical Education and Research, Craig Hospital, Quanterix Corporation, Life Molecular Imaging GmbH, Prothena Corporation plc, Annovis Bio Inc., Noveome Biotherapeutics Inc., Therapeutic Solutions International Inc., Kannalife Sciences Inc., Wund Healing Biopharmaceuticals, The Regents of The University of California, Novoron Bioscience Inc., FibroGenesis LLC, AgoneX Biopharmaceuticals Inc., Nexien Biopharma Inc., PresSura Neuro, and The Stern Lab.

North America was the largest region in the chronic traumatic encephalopathy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in chronic traumatic encephalopathy report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the chronic traumatic encephalopathy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The chronic traumatic encephalopathy market consists of revenues earned by entities by providing services such as personalized medicine planning, telemedicine, genetic testing, occupational therapy, mental health support, cognitive therapy, and patient monitoring. The market value includes the value of related products and medical devices sold by the service providers or included within the service offering. The chronic traumatic encephalopathy market also includes sales of wearable health monitoring devices, brain imaging equipment, neuroprotective supplements, and biomarker assay kits. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Chronic Traumatic Encephalopathy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on chronic traumatic encephalopathy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for chronic traumatic encephalopathy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The chronic traumatic encephalopathy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Treatment: Pharmacological Treatments; Rehabilitation Therapies; Psychological Support; Surgical Interventions; Alternative Therapies
• 2) By Diagnosis Type: Imaging Tests; Neurological Exams; Biomarker Tests; Other Diagnosis Types
• 3) By Disease Type: Early Stage Chronic Traumatic Encephalopathy (CTE); Advanced Stage Chronic Traumatic Encephalopathy (CTE)
• 4) By End-User: Hospitals; Clinics; Research Institutes; Other End-Users
• Subsegments:
• 1) By Pharmacological Treatments: Anti-Inflammatory Drugs; Neuroprotective Agents; Antidepressants; Antipsychotics; Cognitive Enhancers
• 2) By Rehabilitation Therapies: Physical Therapy; Occupational Therapy; Speech Therapy; Cognitive Rehabilitation; Vestibular Therapy
• 3) By Psychological Support: Cognitive Behavioral Therapy (CBT); Support Groups; Counseling Services; Stress Management Programs; Psychiatric Care
• 4) By Surgical Interventions: Craniotomy; Decompressive Surgery; Ventriculoperitoneal Shunt; Deep Brain Stimulation (DBS); Neuroendoscopy
• 5) By Alternative Therapies: Acupuncture; Herbal Medicine; Meditation And Mindfulness; Nutritional Therapy; Chiropractic Treatment
• Companies Mentioned: MedStar Health; NorthShore University Health System; Boston University; Mayo Foundation for Medical Education and Research; Craig Hospital
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Chronic Traumatic Encephalopathy Market Characteristics

3. Chronic Traumatic Encephalopathy Market Trends And Strategies

4. Chronic Traumatic Encephalopathy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Chronic Traumatic Encephalopathy Growth Analysis And Strategic Analysis Framework

• 5.1. Global Chronic Traumatic Encephalopathy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Chronic Traumatic Encephalopathy Market Growth Rate Analysis
• 5.4. Global Chronic Traumatic Encephalopathy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Chronic Traumatic Encephalopathy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Chronic Traumatic Encephalopathy Total Addressable Market (TAM)

6. Chronic Traumatic Encephalopathy Market Segmentation

• 6.1. Global Chronic Traumatic Encephalopathy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmacological Treatments
• Rehabilitation Therapies
• Psychological Support
• Surgical Interventions
• Alternative Therapies
• 6.2. Global Chronic Traumatic Encephalopathy Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Imaging Tests
• Neurological Exams
• Biomarker Tests
• Other Diagnosis Types
• 6.3. Global Chronic Traumatic Encephalopathy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Early Stage Chronic Traumatic Encephalopathy (CTE)
• Advanced Stage Chronic Traumatic Encephalopathy (CTE)
• 6.4. Global Chronic Traumatic Encephalopathy Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Research Institutes
• Other End-Users
• 6.5. Global Chronic Traumatic Encephalopathy Market, Sub-Segmentation Of Pharmacological Treatments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Anti-Inflammatory Drugs
• Neuroprotective Agents
• Antidepressants
• Antipsychotics
• Cognitive Enhancers
• 6.6. Global Chronic Traumatic Encephalopathy Market, Sub-Segmentation Of Rehabilitation Therapies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Physical Therapy
• Occupational Therapy
• Speech Therapy
• Cognitive Rehabilitation
• Vestibular Therapy
• 6.7. Global Chronic Traumatic Encephalopathy Market, Sub-Segmentation Of Psychological Support, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cognitive Behavioral Therapy (CBT)
• Support Groups
• Counseling Services
• Stress Management Programs
• Psychiatric Care
• 6.8. Global Chronic Traumatic Encephalopathy Market, Sub-Segmentation Of Surgical Interventions, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Craniotomy
• Decompressive Surgery
• Ventriculoperitoneal Shunt
• Deep Brain Stimulation (DBS)
• Neuroendoscopy
• 6.9. Global Chronic Traumatic Encephalopathy Market, Sub-Segmentation Of Alternative Therapies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Acupuncture
• Herbal Medicine
• Meditation And Mindfulness
• Nutritional Therapy
• Chiropractic Treatment

7. Chronic Traumatic Encephalopathy Market Regional And Country Analysis

• 7.1. Global Chronic Traumatic Encephalopathy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Chronic Traumatic Encephalopathy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Chronic Traumatic Encephalopathy Market

• 8.1. Asia-Pacific Chronic Traumatic Encephalopathy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Chronic Traumatic Encephalopathy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Chronic Traumatic Encephalopathy Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Chronic Traumatic Encephalopathy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Chronic Traumatic Encephalopathy Market

• 9.1. China Chronic Traumatic Encephalopathy Market Overview
• 9.2. China Chronic Traumatic Encephalopathy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Chronic Traumatic Encephalopathy Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Chronic Traumatic Encephalopathy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Chronic Traumatic Encephalopathy Market

• 10.1. India Chronic Traumatic Encephalopathy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Chronic Traumatic Encephalopathy Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Chronic Traumatic Encephalopathy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Chronic Traumatic Encephalopathy Market

• 11.1. Japan Chronic Traumatic Encephalopathy Market Overview
• 11.2. Japan Chronic Traumatic Encephalopathy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Chronic Traumatic Encephalopathy Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Chronic Traumatic Encephalopathy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Chronic Traumatic Encephalopathy Market

• 12.1. Australia Chronic Traumatic Encephalopathy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Chronic Traumatic Encephalopathy Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Chronic Traumatic Encephalopathy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Chronic Traumatic Encephalopathy Market

• 13.1. Indonesia Chronic Traumatic Encephalopathy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Chronic Traumatic Encephalopathy Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Chronic Traumatic Encephalopathy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Chronic Traumatic Encephalopathy Market

• 14.1. South Korea Chronic Traumatic Encephalopathy Market Overview
• 14.2. South Korea Chronic Traumatic Encephalopathy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Chronic Traumatic Encephalopathy Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Chronic Traumatic Encephalopathy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Chronic Traumatic Encephalopathy Market

• 15.1. Western Europe Chronic Traumatic Encephalopathy Market Overview
• 15.2. Western Europe Chronic Traumatic Encephalopathy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Chronic Traumatic Encephalopathy Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Chronic Traumatic Encephalopathy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Chronic Traumatic Encephalopathy Market

• 16.1. UK Chronic Traumatic Encephalopathy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Chronic Traumatic Encephalopathy Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Chronic Traumatic Encephalopathy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Chronic Traumatic Encephalopathy Market

• 17.1. Germany Chronic Traumatic Encephalopathy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Chronic Traumatic Encephalopathy Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Chronic Traumatic Encephalopathy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Chronic Traumatic Encephalopathy Market

• 18.1. France Chronic Traumatic Encephalopathy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Chronic Traumatic Encephalopathy Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Chronic Traumatic Encephalopathy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Chronic Traumatic Encephalopathy Market

• 19.1. Italy Chronic Traumatic Encephalopathy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Chronic Traumatic Encephalopathy Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Chronic Traumatic Encephalopathy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Chronic Traumatic Encephalopathy Market

• 20.1. Spain Chronic Traumatic Encephalopathy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Chronic Traumatic Encephalopathy Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Chronic Traumatic Encephalopathy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Chronic Traumatic Encephalopathy Market

• 21.1. Eastern Europe Chronic Traumatic Encephalopathy Market Overview
• 21.2. Eastern Europe Chronic Traumatic Encephalopathy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Chronic Traumatic Encephalopathy Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Chronic Traumatic Encephalopathy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Chronic Traumatic Encephalopathy Market

• 22.1. Russia Chronic Traumatic Encephalopathy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Chronic Traumatic Encephalopathy Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Chronic Traumatic Encephalopathy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Chronic Traumatic Encephalopathy Market

• 23.1. North America Chronic Traumatic Encephalopathy Market Overview
• 23.2. North America Chronic Traumatic Encephalopathy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Chronic Traumatic Encephalopathy Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Chronic Traumatic Encephalopathy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Chronic Traumatic Encephalopathy Market

• 24.1. USA Chronic Traumatic Encephalopathy Market Overview
• 24.2. USA Chronic Traumatic Encephalopathy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Chronic Traumatic Encephalopathy Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Chronic Traumatic Encephalopathy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Chronic Traumatic Encephalopathy Market

• 25.1. Canada Chronic Traumatic Encephalopathy Market Overview
• 25.2. Canada Chronic Traumatic Encephalopathy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Chronic Traumatic Encephalopathy Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Chronic Traumatic Encephalopathy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Chronic Traumatic Encephalopathy Market

• 26.1. South America Chronic Traumatic Encephalopathy Market Overview
• 26.2. South America Chronic Traumatic Encephalopathy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Chronic Traumatic Encephalopathy Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Chronic Traumatic Encephalopathy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Chronic Traumatic Encephalopathy Market

• 27.1. Brazil Chronic Traumatic Encephalopathy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Chronic Traumatic Encephalopathy Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Chronic Traumatic Encephalopathy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Chronic Traumatic Encephalopathy Market

• 28.1. Middle East Chronic Traumatic Encephalopathy Market Overview
• 28.2. Middle East Chronic Traumatic Encephalopathy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Chronic Traumatic Encephalopathy Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Chronic Traumatic Encephalopathy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Chronic Traumatic Encephalopathy Market

• 29.1. Africa Chronic Traumatic Encephalopathy Market Overview
• 29.2. Africa Chronic Traumatic Encephalopathy Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Chronic Traumatic Encephalopathy Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Chronic Traumatic Encephalopathy Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Chronic Traumatic Encephalopathy Market Competitive Landscape And Company Profiles

• 30.1. Chronic Traumatic Encephalopathy Market Competitive Landscape
• 30.2. Chronic Traumatic Encephalopathy Market Company Profiles
  • 30.2.1. MedStar Health Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. NorthShore University Health System Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Boston University Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Mayo Foundation for Medical Education and Research Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Craig Hospital Overview, Products and Services, Strategy and Financial Analysis

31. Chronic Traumatic Encephalopathy Market Other Major And Innovative Companies

• 31.1. Quanterix Corporation
• 31.2. Life Molecular Imaging GmbH
• 31.3. Prothena Corporation plc
• 31.4. Annovis Bio Inc.
• 31.5. Noveome Biotherapeutics Inc.
• 31.6. Therapeutic Solutions International Inc.
• 31.7. Kannalife Sciences Inc.
• 31.8. Wund Healing Biopharmaceuticals
• 31.9. The Regents of The University of California
• 31.10. Novoron Bioscience Inc.
• 31.11. FibroGenesis LLC
• 31.12. AgoneX Biopharmaceuticals Inc.
• 31.13. Nexien Biopharma Inc.
• 31.14. PresSura Neuro
• 31.15. The Stern Lab

32. Global Chronic Traumatic Encephalopathy Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Chronic Traumatic Encephalopathy Market

34. Recent Developments In The Chronic Traumatic Encephalopathy Market

35. Chronic Traumatic Encephalopathy Market High Potential Countries, Segments and Strategies

• 35.1 Chronic Traumatic Encephalopathy Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Chronic Traumatic Encephalopathy Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Chronic Traumatic Encephalopathy Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer